LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Human Resources for Health in Rwanda

Shubhada Hooli, MD, MPH
Samantha Rosman, MD
Daphne Remy, MD

Other Affiliated Faculty

Lara Antkowiak, MD
MaryCatherine Arbour, MD, MPH
Natasha Archer, MD
Lisa Butler, PhD, MPH
Grace Chan, MD, PhD, MPH
Christopher Duggan, MD, MPH
Sara Gonzalez, DO
Anne Hansen, MD, MPH
Vibha Krishnamurthy, MD
Anne CC Lee, MD, MPH
Leslie Lehmann, MD
Duncan Maru, MD, PhD
Kenneth McIntosh, MD
Carlos Rodriguez-Galindo, MD
Peter Rohloff, MD, PhD
Dennis Rosen, MD
Sadath Sayeed, MD, JD
Janet Scott Lloyd, MD
Diane Stafford, MD
Venee Tubman, MD
Julia von Oettingen, MD

Christopher Duggan, MD, MPH

Associate Professor of Pediatrics, Harvard Medical School; Associate Professor in the Department of Nutrition, Harvard School of Public Health; Director, Center for Nutrition, Boston Children’s Hospital; Medical Director, Center for Advanced Intestinal Rehabilitation (CHAIR), Boston Children’s Hospital

For the past 20 years, Christopher Duggan, M.D., M.P.H. has been performing clinical trials in the fields of pediatric nutrition, gastroenterology and global health. His early work centered on the management of diarrheal diseases in children, including trials that demonstrated the feasibility and efficacy of oral rehydration solutions (ORS) for diarrhea management in the US and globally. In collaboration with colleagues at Harvard and Muhimbili University of Health and Allied Sciences in Dar es Salaam, Tanzania, Dr. Duggan is evaluating the efficacy of micronutrient supplementation in infants and young children born to women with or at risk of HIV infection, as well as investigating the role of biomarkers to detect environmental enteropathy. With colleagues at St John's Research Institute in Bangalore, India, he is evaluating the efficacy of maternal vitamin B12 supplementation on biochemical and clinical parameters during pregnancy and infancy. Past and present research support has come from the National Institutes of Health, the Bill and Melinda Gates Foundation, and numerous foundations.

Anne Hansen, MD, MPH

Associate in Medicine, Medical Director, Neonatal Intensive Care Unit, Boston Children’s Hospital; Associate Professor of Pediatrics, Harvard Medical School

Dr. Hansen’s global health work is focused on improving newborn medicine in Rwanda, in collaboration with Rwandan health care providers, professional societies, the ministry of health and Partners In Health (PIH). Starting in 2010, Dr Hansen began to help develop and implement a newborn medicine protocol that has been accepted as the Rwandan national standard for newborn care. Since then she has worked to increase capacity, including the use of bubble CPAP. Most recently she has helped write the 2nd edition of the National Protocol to reflect this increased capacity, with planned national training in 2015. She has also working with Lawrence Berkeley Laboratory’s Institute for Globally Transformative Technologies (LIGGT) and PIH since 2012 to develop and test a non-electric infant warmer. This project is currently approaching completion of prototype development and safety testing, and is expected to move to clinical trials in Rwanda in 2105. Finally, she is working with the Wyss Institute to develop a bedside test as an alternative to the blood culture in the resource limited setting, based on a modified version of Mannose Binding Lectin, engineered to capture small quantities of bacteria in a blood sample. This project is still in the development phase. In addition to her efforts in global health, she works to improve the care of newborns seriously ill with medical and surgical conditions. She has authored both original research papers and manuals for neonatologists, surgeons and pediatricians, developed multiple guidelines for the CHB NICU, and collaborated with numerous investigators on medical and technical improvements to care. For surgical patients, she co-edited The Manual of Neonatal Surgical Intensive Care, editions 1 to 3. She has written multiple guidelines for pre and post operative management. She was a lead investigator in a study of Donation after Cardiac Death (DCD) in the NICU that resulted in offering this option in the CHB NICU. She is currently working with a team that includes BCH surgery and the Wyss Institute to develop a novel, minimally invasive approach to growth induction via stretch, applicable to patients with long gap esophageal atresia. For medical patients, she has co-edited the Manual of Neonatal Care, and studied innovative approaches to the treatment of neonatal conditions including intraventricular urokinase for the prevention of posthemorrhagic hydrocephalus, once daily gentamicin dosing in infants, substitution of cord for infant blood in peri-natal sepsis evaluations, and inhaled racemic epinephrine for the treatment of TTN. In collaboration with her neurology colleagues, she helped develop and implement the first therapeutic hypothermia program in New England and is collaborating on studies of sophisticated MRI and NIRS technology to better assess neurologic function and outcome.

Kenneth McIntosh, MD

Senior Physician in Medicine, Division of Infectious Diseases, Boston Children’s Hospital; Professor of Pediatrics, Harvard Medical School;

I finished residency in 1965, spent 4 years doing research on respiratory viruses at the National Institutes of Health and then accepted a position as Chief of Pediatric Infectious Diseases at the University of Colorado Medical School in Denver, where I spent 10 years. In 1979 I was asked to be first Clinical Chief, and then Chief of the Division of Infectious Diseases at Boston Children’s Hospital. I stepped down from this position in 2000 and am now “semi-retired”. My research interests have been general pediatric infectious diseases, development of viral diagnostics, respiratory viruses (coronaviruses, respiratory syncytial virus, others), and, since 1985, pediatric HIV (its prevention, management, treatment, and complications). I became interested in global health in the early 1980’s, first in the application of simple viral diagnostics in global pediatrics, and later in the spread of the HIV epidemic in Africa and Asia.

Peter Rohloff, MD, PhD

Associate Physician, Department of Global Health Equity, Brigham and Women’s Hospital; Associate Physician, Department of General Internal Medicine, Brigham and Women’s Hospital; Associate Physician, Hospitalist Division, Dana Farber Cancer Institute; Instructor in Medicine, Harvard Medical School; Medical Director, Maya Health Alliance (Wuqu’ Kawoq); Contributing Author, Global Health Hub

I am a board-certified internist (BWH, 2012), pediatrician (BCRP, 2012) and parasitologist (PhD, University of Illinois, 2003). In addition to a strong background in tropical medicine and parasitic illnesses, I have been working as the Medical Director of a nongovernmental organization, the Maya Health Alliance, in Guatemala since 2007. When not in Central America, I work in the departments of General Internal Medicine and Global Health Equity at Brigham and Women’s Hospital. I also occasionally precept residents in an outpatient med-peds setting. My major research interests include the management of noncommunicable illnesses in resource poor settings, indigenous peoples and health disparities, and child stunting. I have a strong background in mixed methodologies in global health, especially those incorporating community participatory research and ethnography. I am the recent recipient of the HMS Dean’s Community Service Award (2010), Guatemala’s Order of the Monja Blanca, Second Class (2013), and the Velji Award for Faculty Teaching Excellence in Global Health from the Consortium of Universities for Global Health (2014).

Julia von Oettingen, MD, Dr. Med

Fellow in Pediatric Endocrinology, Boston Children’s Hospital; Medical Director, Kay Mackenson Center (St. Marc, Haiti); Clinical Fellow in Pediatrics, Harvard Medical School; Committee Member, Massachusetts Medical Society Global Health Committee; Co-Director, Massachusetts Medical Society Global Health Student Conference; Council Member, Pediatric Endocrine Society International Relations Council;

Dr. von Oettingen is a fellow in pediatric endocrinology at Boston Children’s Hospital, and a master student in the Harvard Catalysts’ Master Program in Clinical and Translational Investigation. She completed her medical school training in her home country, Germany, and spent elective time in Brazil, Bulgaria, Burkina Faso, Peru and Canada. Her doctorate research was at McGill University in Montreal, Canada, in a tropical medicine and infectious diseases laboratory, and she graduated summa cum laude. She was a pediatric resident in Germany for a year before completing her pediatric training at Boston’s Massachusetts General Hospital for Children. Dr. von Oettingen’s global health work has focused on non-communicable diseases and health care infrastructure in Liberia and Haiti. She was involved with the development of a new model for pediatric primary care in Liberia, and led efforts to establish juvenile diabetes care in the country with a network of collaborators including pediatric endocrinologists, global health experts, local medical providers, diabetes patient activists and with major support from the International Diabetes Federation (IDF)’s Life for a Child program (www.idf.org/lifeforachild). In January 2013, Dr. von Oettingen took on the position of medical director of Kay Mackenson Center, a newly inaugurated pediatric chronic diseases clinic in Haiti. She provides and supervises clinical care, staff education, and is developing the center’s research program. Planned clinical research projects include the study of pediatric diabetes phenotypes, and the investigation of lead levels, iodine insufficiency and vitamin D status in Haitian children. Dr. von Oettingen speaks German, English, French, Spanish, Portuguese, and is conversational in Persian and Creole, allowing her to communicate with many of her patients in their native tongue. 

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO